Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06269445
What this trial is testing

The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sir Run Run Shaw Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03428477
What this trial is testing

EPA for Metastasis Trial 2

Who this might be right for
Liver MetastasisColon Cancer
Mark A Hull, PhD FRCP 418
Large-scale testing (Phase 3)Study completedNCT02162563
What this trial is testing

Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Dutch Colorectal Cancer Group 530
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Study completedNCT03893695
What this trial is testing

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

Who this might be right for
Metastatic Hepatocellular CarcinomaHCCCombinations of Drugs; Dependence
Suzhou Kintor Pharmaceutical Inc, 20
Not applicableStudy completedNCT07559851
What this trial is testing

Ablation With Systemic Therapy vs Liver Resection With Systemic Therapy for Colorectal Liver Metastasis

Who this might be right for
Colorectal Liver Metastasis (CRLM)
The First Hospital of Jilin University 151
Testing effectiveness (Phase 2)Looking for participantsNCT06792695
What this trial is testing

Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AstraZeneca 80
Not applicableNot Yet RecruitingNCT07391007
What this trial is testing

Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Fudan University 200
Large-scale testing (Phase 3)Looking for participantsNCT02885753
What this trial is testing

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 348
Not applicableWithdrawnNCT01631539
What this trial is testing

Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC

Who this might be right for
Liver MetastasesColorectal Cancer
Universitaire Ziekenhuizen KU Leuven
Early research (Phase 1)Study completedNCT01437007
What this trial is testing

TKM 080301 for Primary or Secondary Liver Cancer

Who this might be right for
Colorectal Cancer With Hepatic MetastasesPancreas Cancer With Hepatic MetastaseGastric Cancer With Hepatic Metastase+2 more
National Cancer Institute (NCI) 1
Not applicableUnknownNCT00522509
What this trial is testing

Preoperative Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Colorectal Liver Metastases
IRCCS San Raffaele
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Not applicableActive Not RecruitingNCT04161092
What this trial is testing

The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Liver Metastases
Vastra Gotaland Region 45
Testing effectiveness (Phase 2)Looking for participantsNCT06300463
What this trial is testing

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesColorectal Cancer
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)UnknownNCT04003792
What this trial is testing

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Who this might be right for
Liver Metastasis Colon Cancer
Rabin Medical Center 49
Early research (Phase 1)Active Not RecruitingNCT03028311
What this trial is testing

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Who this might be right for
Metastatic Liver CarcinomaStage IV Liver CancerStage IVA Liver Cancer+1 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04631744
What this trial is testing

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 4
Not applicableStudy completedNCT01891552
What this trial is testing

Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab

Who this might be right for
Colon Cancer Liver Metastasis
International Group of Endovascular Oncology 40
Next Page